| Description |
1 online resource (934 pages) |
| Contents |
Cover Page; Title Page; Copyright Page; Preface; Contents; List of abbreviations; Historical introduction; Part 1 General properties of antimicrobial agents; 1 Inhibitors of bacterial cell wall synthesis; 2 Inhibitors of bacterial protein synthesis; 3 Synthetic antibacterial agents and miscellaneous antibiotics; 4 Antiviral agents; 5 Antiretroviral agents; 6 Drugs used in the treatment of viral hepatitis; 7 Antifungal agents; 8 Antiprotozoal and anthelminthic agents; Part 2 Resistance to antimicrobial agents; 9 The problem of resistance; 10 The genetics and mechanisms of acquired resistance |
|
11 Control of the spread of resistance and Clostridium difficile infectionPart 3 General principles of usage of antimicrobial agents; 12 Laboratory investigations and the treatment of infection; 13 General principles of the treatment of infection; 14 Pharmacokinetic and pharmacodynamic principles; 15 Prescribing in children and the elderly; 16 Outpatient parenteral antimicrobial therapy (OPAT); 17 Adverse drug reactions; 18 Chemoprophylaxis and immunization; 19 Guidelines, formularies, and antimicrobial policies |
|
20 Antibiotic stewardship and the multi-professional antimicrobial management teamPart 4 Therapeutic use of antimicrobial agents; 21 Respiratory tract infections; 22 Topical use of antimicrobial agents; 23 Urinary infections; 24 Sexually transmitted infections; 25 Gastrointestinal infections; 26 Serious bloodstream infections; 27 Bone and joint infections; 28 Infections of the central nervous system; 29 Skin and soft tissue infections; 30 Tuberculosis and other mycobacterial diseases; 31 Infections in immunocompromised patients including HIV/AIDS; 32 Viral infections |
|
33 Management of HIV infection34 Treatment of chronic viral hepatitis; 35 Parasitic diseases; 36 The development and marketing of antimicrobial drugs; Recommendations for further reading; Index |
| Summary |
Antimicrobial agents are essential for the treatment of life-threatening infections and for managing the burden of minor infections in the community. In addition, they play a key role in organ and bone marrow transplantation, cancer chemotherapy, artificial joint and heart valve surgery. Unlike other classes of medicines, they are vulnerable to resistance from mutations in target microorganisms, and their adverse effects may extend to other patients (increased risk ofcross-infection). As a consequence, there is a constant requirement for new agents, as well as practices that ensure the continu |
| Notes |
Print version record |
| Subject |
Anti-infective agents.
|
|
Communicable diseases -- Chemotherapy
|
|
Therapeutics.
|
|
Drug resistance in microorganisms.
|
|
Anti-Infective Agents -- therapeutic use
|
|
Therapeutics
|
|
Anti-Infective Agents -- pharmacology
|
|
Drug Resistance, Microbial
|
|
Infections -- drug therapy
|
|
Anti-Infective Agents
|
|
treating (health care function)
|
|
Therapeutics
|
|
Drug resistance in microorganisms
|
|
Anti-infective agents
|
|
Communicable diseases -- Chemotherapy
|
| Form |
Electronic book
|
| Author |
Davey, Peter
|
|
Wilcox, Mark H
|
| ISBN |
9780191628658 |
|
0191628654 |
|
